Abbott's India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain

Indian authorities are scrutinizing the supply chain of Abbott Healthcare as part of a broader investigation into the alleged misuse and diversion of codeine-based cough syrups.

Abbott Healthcare halted production of Phensedyl in December 2024, citing persistent misuse despite safeguards. However, the drug is reportedly active within existing supply channels.

Regulators claim large volumes continue to circulate in the market, raising concerns about non-therapeutic use and possible abuse.

Phensedyl contains codeine, a narcotic commonly used in cough suppressants but also prone to misuse. The syrup has historically been smuggled into neighboring ...